Skip to content

Perioperative Management of DIEP Flaps

Perioperative Management of Deep Inferior Epgastric Perforator (DIEP) Flap for Breast Reconstruction

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03118024
Enrollment
100
Registered
2017-04-18
Start date
2017-03-13
Completion date
2019-03-31
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mammaplasty, Microsurgery, Free Tissue Flaps

Keywords

deep inferior epigastric perforator flap, fluid restriction, catecholamine restriction

Brief summary

By comparison of two different protocols with diverse fluid/ catecholamine administration limits (fluid restriction vs. catecholamine restriction with target systolic blood pressure \> 100 mmHg) the investigators would like to reveal the impact of intraoperative blood pressure management on the survival rate of free deep inferior epigastric artery flaps for breast reconstruction.

Interventions

crystalloid restrictive anesthesia protocol

catecholamine restrictive anesthesia protocol

Sponsors

University of Regensburg
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Informed consent for study participation * Every patient undergoing breast reconstruction (primary and secondary reconstruction) with deep inferior epigastric perforator flap at our hospital is offered to participate in the study

Exclusion criteria

* No informed consent for study participation * Patients with a high thromboembolic risk profile * During pregnancy and breastfeeding * Minors * Patients with a health care proxy

Design outcomes

Primary

MeasureTime frameDescription
Free flap survival rate5 days postoperativelyRates of (partial) flap loss in each study arm

Secondary

MeasureTime frameDescription
Period of hospitalizationup to 14 daysLength of postoperative hospitalization in each study arm

Countries

Germany

Contacts

Primary ContactAlexandra Anker, MD
aanker@caritasstjosef.de0049 941 782 3110

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026